Data / Research funding / Virginia / Eastern Virginia Medical School
Eastern Virginia Medical School: 26 NIH awards ($20.2M), fiscal years 2021 to 2026
Eastern Virginia Medical School in Norfolk, VA is funded under 26 NIH awards ($20.2M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- CTLVX9M7AMR4
- State
- Virginia
Awards
26 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | NIH | National Cancer Institute | 2021 to 2023 | $2,755,707 | August 7, 2020 | April 30, 2024 | PLUNK, ANDREW DUANE | reporter.nih.gov |
| Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $2,062,981 | February 1, 2019 | June 30, 2024 | CLARK, MEREDITH R | reporter.nih.gov |
| CSF1R Signaling in Age-Related HIV Neurodegeneration | NIH | National Institute of Mental Health | 2021 to 2022 | $1,723,127 | August 15, 2019 | December 15, 2022 | KIM, WOONG-KI | reporter.nih.gov |
| The mechanisms of cardiac thin filament regulation in health and disease. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,576,930 | January 1, 2022 | June 30, 2024 | GALKIN, VITOLD | reporter.nih.gov |
| Role of the NLRP3 Inflammasome in Mediating Microglial Activation and Development of Neuropsychiatric Symptoms Induced by HIV, Antiretrovirals and Cocaine | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,515,246 | August 15, 2021 | June 30, 2024 | GUO, MINGLEI | reporter.nih.gov |
| Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,274,417 | August 1, 2020 | June 25, 2024 | MATROUGUI, KHALID | reporter.nih.gov |
| Virginia-UCLA-Toronto Biomarker Characterization Center | NIH | National Cancer Institute | 2022 to 2023 | $1,234,117 | September 2, 2022 | June 30, 2024 | SEMMES, OLIVER JOHN | reporter.nih.gov |
| Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,108,121 | July 1, 2020 | June 25, 2024 | MATROUGUI, KHALID | reporter.nih.gov |
| Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,052,953 | February 12, 2019 | January 31, 2022 | CLARK, MEREDITH R | reporter.nih.gov |
| Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | NIH | National Institute on Minority Health and Health Disparities | 2023 | $773,418 | November 1, 2022 | June 30, 2024 | ENGLAND, KELLI | reporter.nih.gov |
| Impact of atherosclerosis, metabolic syndrome, and STAT4-dependent immunity on Alzheimer's disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $766,084 | April 1, 2018 | February 28, 2023 | GALKINA, ELENA V | reporter.nih.gov |
| A-to-I RNA modifications in mouse oocytes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $647,968 | August 26, 2019 | June 30, 2024 | BRACHOVA, PAVLA | reporter.nih.gov |
| B cell anergy, modified LDL uptake, and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $483,862 | April 1, 2018 | March 31, 2024 | GALKINA, ELENA V | reporter.nih.gov |
| Cannabinoid-2 receptor signaling in vesicant induced lung injury | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $432,598 | August 18, 2021 | June 30, 2024 | NAGRE, NAGARAJA | reporter.nih.gov |
| Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | NIH | National Heart, Lung, and Blood Institute | 2024 | $400,325 | April 1, 2024 | June 30, 2024 | SANDERS, YAN | reporter.nih.gov |
| Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer | NIH | National Cancer Institute | 2021 | $347,662 | September 15, 2016 | August 31, 2022 | SEMMES, OLIVER JOHN | reporter.nih.gov |
| Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2024 | $343,311 | February 1, 2024 | June 30, 2024 | SANDERS, YAN | reporter.nih.gov |
| CCTN-PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $310,399 | September 28, 2018 | September 27, 2023 | ARCHER, DAVID | reporter.nih.gov |
| Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $267,258 | January 15, 2021 | June 30, 2024 | POPOVICS, PETRA | reporter.nih.gov |
| An Aptamer-Based Biosensor for Point-of-Care Monitoring of Adherence to Oral Tenofovir Antiretroviral Regimens for HIV Prevention and Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $253,552 | February 18, 2020 | January 31, 2023 | JACOT, TERRY ANN | reporter.nih.gov |
| Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | NIH | National Cancer Institute | 2023 to 2024 | $210,376 | May 1, 2023 | June 30, 2024 | KERSCHER, AURORA ESQUELA | reporter.nih.gov |
| Does Tobacco Social Media Marketing Alter Adolescent Risk Perceptions and Use? Longitudinal Data-Adaptive Estimators and Causal Inference to Enhance Understanding | NIH | National Cancer Institute | 2023 | $174,022 | September 25, 2023 | June 30, 2024 | HARRELL, PAUL TRUMAN | reporter.nih.gov |
| Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | NIH | National Cancer Institute | 2024 | $167,853 | August 7, 2020 | June 30, 2024 | SHEEHAN, BRYNN | reporter.nih.gov |
| Designing effective RNA therapies for oocyte maturation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $108,996 | September 1, 2023 | June 30, 2024 | ALVAREZ, NEHEMIAH SETH | reporter.nih.gov |
| NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $108,606 | August 1, 2025 | February 28, 2026 | ARCHER, DAVID FITZGERALD | reporter.nih.gov |
| Identification and characterization of a new pericyte subset: Role in blood-brain barrier breakdown | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $60,789 | September 18, 2020 | July 30, 2023 | BOHANNON, DIANA GAIL | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1 | $96,167 | 0 | $0 |
| 2024 | 8 | $1,530,622 | 0 | $0 |
| 2023 | 14 | $4,591,946 | 0 | $0 |
| 2022 | 12 | $7,392,575 | 0 | $0 |
| 2021 | 13 | $6,549,368 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Prevention
- Clinical Research
- Contraception/Reproduction
- Infectious Diseases
- Women's Health
- Genetics
- Biotechnology
- Aging
- Cardiovascular
- HIV/AIDS
- Neurosciences
- Rare Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.